Yunnan Baiyao Group

Yunnan Baiyao Group is one of the...

• CSI 300;
• Forbes Global 2000 (#1936).

Yunnan Baiyao Group is a company listed under the stock ticker 000538 (CN).

View the org chart displaying its 18 main executives

Most searched biographies at Yunnan Baiyao Group

• Ming Dong, Acting Chairman of the Board, President and Chief Execu...
• Hongshen Li, Director
• Yanhui Chen, Director

Create your alert
to follow the executive moves at Yunnan Baiyao Group.

Yunnan Baiyao Group has 1,868 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Yunnan Baiyao Group

Social media about Yunnan Baiyao Group

• Yunnan Baiyao Group on Wikipedia, Google News & Yahoo Finance
• Yunnan Baiyao Group on LinkedIn, Twitter & YouTube

Contact by email its executives including Ming Dong

Call Yunnan Baiyao Group at +86 871...

View the org chart

Register to receive your alert

Report an error